Medical Therapy of Breast Cancer

Inbunden, Engelska, 2003

2 146 kr

Beställningsvara. Skickas inom 7-10 vardagar. Fri frakt över 249 kr.

Beskrivning

There have been very significant advances across many areas of the study, investigation and treatment of breast cancer. This publication surveys how scientific advances have influenced, improved and extended therapeutic options. The volume spans prevention, screening, genetics, and treatment of pre-invasive breast cancer, before focusing in depth on management of established breast cancer. This includes chapters on the various therapeutic options available and their role in treating breast cancer from the very earliest stage through to advanced and metastatic breast cancer. In addition, the text looks forward at the potential for emerging experimental strategies to become adopted into medical management in the future. The volume concludes with a chapter on palliative care. This wide-ranging account will be essential for breast cancer specialists, trainees in oncology and clinical research scientists.

Produktinformation

Utgivningsdatum:2003-01-09
Mått:179 x 256 x 26 mm
Vikt:1 033 g
Format:Inbunden
Språk:Engelska
Antal sidor:414
Förlag:Cambridge University Press
ISBN:9780521496322

Utforska kategorier

Onkologi inom Medicin

Mer om författaren

Zenon Rayter is Consultant Surgeon at Bristol Royal Infirmary and Honorary Senior Lecturer at the University of Bristol. He is Director of the Bristol Breast Unit, Chairman of the Breast Site Specialist Group of Avon, Somerset and Wiltshire Cancer Services, and Vice President of the Surgical Section of the Royal Society of Medicine. Janine Mansi is Consultant Medical Oncologist and Honorary Senior Lecturer at St George's Hospital Medical School, Regional Speciality Advisor for Medical Oncology for South West London and an executive member of the Association of Cancer Physicians.

Recensioner i media

Review of the hardback: 'The text is thorough, concise, and comprehensive to an extent which is consonant with its size. Factual information is pertinent, up-to-date, and presented with clarity and lack of bias. Controversial issues are discussed in a stimulating and non-dogmatic way with some insightful comments.' The Lancet

Innehållsförteckning

List of contributors; 1. History of breast cancer therapy Zenon Rayter; 2. Chemoprevention of breast cancer Tamas Hickish; 3. Familial breast cancer H. Gogas and V. Murday; 4. Hormone replacement therapy and breast cancer J. Marsden and N. P. M. Sacks; 5. Screening for breast cancer Rosalind Given-Wilson; 6. The management of in situ breast cancer Zenon Rayter; 7. Adjuvant systematic therapy T. R. J. Evans; 8. Adjuvant radiotherapy in the management of breast cancer Gillian Ross, David Landau and Andrew Tutt; 9a. Cell kinetic parameters and response to therapy R. S. Camplejohn; 9b. Predictors of response and resistance to medical therapy: endocrine therapy Zenon Rayter; 9c. Predictors of response and resistance to medical therapy: chemotherapy Stephen R. D. Johnson; 10. Primary medical therapy in breast cancer Janine L. Mansi; 11. Medical therapy of advanced disease Alison Jones and Karen McAdam; 12a. High dose chemotherapy in breast cancer John Crown and R. C. F. Leonard; 12b. New immunological approaches to treatment for breast cancer A. G. Dalgleish; 13. The place of bisphosphonates in the management of breast cancer A. H. G. Paterson; 14. Palliative care in breast cancer Janet Hardy; Index.